News Image

Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™

Provided By GlobeNewswire

Last update: Oct 6, 2025

- Results published in Oxford Academic’s Military Medicine Journal -

- After up to 18 months of follow-up patients were observed to have zero infections, amputations or deaths and a high rate of patency -

Read more at globenewswire.com

HUMACYTE INC

NASDAQ:HUMA (10/9/2025, 9:17:33 PM)

After market: 1.6497 +0.01 (+0.59%)

1.64

-0.05 (-2.96%)



Find more stocks in the Stock Screener

HUMA Latest News and Analysis

3 days ago - By: Chartmill - Mentions: BTM AEHR APVO PCSA ...
Follow ChartMill for more